Related Experiment Video
Updated: Aug 11, 2026
08:53
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
Immune reactions in classical Hodgkin's lymphoma
S Poppema1, M Potters, R Emmens
1Department of Pathology and Laboratory Medicine, University Hospital Groningen, The Netherlands.
Seminars in Hematology
|August 26, 1999
Summary
Classical Hodgkin's lymphoma (HL) involves a prominent local immune reaction and a systemic immune deficiency. Reed-Sternberg cells drive HL symptoms and immune evasion through cytokine secretion.
Area of Science:
- Oncology
- Immunology
Background:
- Classical Hodgkin's lymphoma (HL) exhibits a unique and pronounced inflammatory response within affected tissues.
- Patients with HL often display a generalized acquired cellular immune deficiency, potentially linked to tumor presence.
Purpose of the Study:
- To elucidate the complex immune reactions associated with classical Hodgkin's lymphoma.
- To understand the role of Reed-Sternberg cells in HL pathogenesis and immune evasion.
Main Methods:
- Review and synthesis of existing literature on the immune response in Hodgkin's lymphoma.
- Analysis of the cellular origin and function of Reed-Sternberg cells.
Main Results:
- HL is characterized by a significant local inflammatory infiltrate and a systemic immune deficiency.
- Reed-Sternberg cells, identified as neoplastic B cells, secrete cytokines/chemokines that induce HL symptoms, promote tumor growth, and facilitate immune evasion.
- Histological features of HL, including inflammation and fibrosis, may stem from Reed-Sternberg cell-derived molecules.
Conclusions:
- The immune microenvironment in HL is critically shaped by Reed-Sternberg cells.
- Understanding these immune dynamics is key to comprehending HL pathogenesis and developing targeted therapies.
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...